Ingrassia T S, Ryu J H, Trastek V F, Rosenow E C
Division of Thoracic Diseases, Mayo Clinic, Rochester, MN 55905.
Mayo Clin Proc. 1991 Feb;66(2):173-8. doi: 10.1016/s0025-6196(12)60489-3.
Bleomycin is an antineoplastic agent with potential for producing pulmonary toxicity, attributed in part to its free radical-promoting ability. Clinical and research experiences have suggested that the risk of bleomycin-induced pulmonary injury is increased with the administration of oxygen. We report a case in which the intraoperative administration of oxygen in the setting of previous bleomycin therapy contributed to postoperative ventilatory failure. Our patient recovered with corticosteroid therapy. Physician awareness of a potential interaction between oxygen and bleomycin may help reduce the morbidity and mortality related to bleomycin therapy.
博来霉素是一种具有产生肺毒性潜力的抗肿瘤药物,部分原因在于其促进自由基生成的能力。临床和研究经验表明,使用氧气会增加博来霉素所致肺损伤的风险。我们报告了一例病例,该患者既往接受过博来霉素治疗,术中使用氧气导致术后呼吸衰竭。我们的患者经皮质类固醇治疗后康复。医生了解氧气与博来霉素之间的潜在相互作用可能有助于降低与博来霉素治疗相关的发病率和死亡率。